Brimonidine Tartrate 70359-46-5 IOP lowing
Inkokhelo:T/T, L/C
Umsuka Womkhiqizo:China
Imbobo yokuthutha:Beijing/Shanghai/Hangzhou
Amandla okukhiqiza:5kg/ngenyanga
I-oda(MOQ):1g
Isikhathi esiholayo:3 Izinsuku Zokusebenza
Isimo sesitoreji:Igcinwe endaweni epholile, eyomile, izinga lokushisa legumbi.
Impahla yephakheji:ibhodlela, ibhodlela
Usayizi wephakheji:1g/ibhodlela, 5/ibhodlela, 10g/ibhodlela, 50g/ibhodlela, 500g/ibhodlela
Ulwazi lokuphepha:UN 2811 6.1/PG 3

Isingeniso
I-Brimonidine umuthi osetshenziselwa ukwelapha i-glaucoma evulekile, i-ocular hypertension, ne-rosacea.Ku-rosacea kuthuthukisa ububomvu.Isetshenziswa njengamaconsi esweni noma ifakwe esikhumbeni.
Imiphumela emibi evamile lapho isetshenziswa emehlweni ihlanganisa ukulunywa, ububomvu, nomlomo owomile.Imiphumela emibi evamile lapho isetshenziswa esikhumbeni ihlanganisa ububomvu, ukuvutha, kanye nekhanda elibuhlungu.Imiphumela emibi ebaluleke kakhulu ingase ihlanganise ukungezwani komzimba nomfutho wegazi ophansi.Ukusetshenziswa ekukhulelwe kubonakala kuphephile.Uma isetshenziswa esweni isebenza ngokunciphisa inani lamahlaya ane-aqueous enziwayo ngenkathi ikhulisa inani eliphuma esweni.Uma ifakwa esikhumbeni isebenza ngokubangela ukuthi imithambo yegazi ifinyele.
Ukucaciswa (izinga lasendlini)
Into | Ukucaciswa |
Ukubukeka | Impushana emhlophe noma ephuzi kancane noma ensundu kancane |
Ukuhlonza | I-HPLC: Isikhathi sokugcina se-HPLC sesampula kufanele sihambisane naleso sezinga lereferensi. |
Ukulahlekelwa ekomisweni | ≤1.0% |
Izinsalela ekushiseni | ≤0.2% |
Izinsimbi ezinzima | ≤20ppm |
Ukujikeleza okuqondile kokubona | +9.0°~+10.5° |
Izinto ezihlobene (HPLC) | Ukungcola okungashiwongo ≤0.1% |
Ukungcola okuphelele ≤0.2% | |
Isivivinyo | 99.0%~101.0% |